Th17 subsets: Differential roles in immune defense mechanisms at the G-I mucosa
Th17 亚群:G-I 粘膜免疫防御机制中的不同作用
基本信息
- 批准号:8180220
- 负责人:
- 金额:$ 32.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:Adenylate CyclaseAdjuvantAdoptive TransferAffectAnimal ModelAnimalsCD4 Positive T LymphocytesCell Differentiation processCell physiologyCellsCholera ToxinColitisCyclic AMPDataDefense MechanismsFrequenciesFutureG Protein-Coupled Receptor GenesGenesHelicobacter pyloriHomingHost DefenseImmuneImmunotherapyIn VitroInfectionInflammationInflammatoryInflammatory disease of the intestineInterleukin-17Interleukin-2Interleukin-6InterventionLaboratoriesLamina PropriaLymphocyte SubsetLymphoidMediatingMesenteryModelingMucosal ImmunityMucositisMucous MembraneMusOrganPathologyPharmaceutical PreparationsPhenotypePhysiologicalPrincipal InvestigatorPropertyProteinsRegulationResearchRoleSignal TransductionSpleenSurfaceSystemT-LymphocyteTestingWild Type Mousebasecytokinedesignin vivoinsightlymph nodesmicrobialmucosal sitenovelpathogenreceptorresponsetranscription factorvaccine development
项目摘要
DESCRIPTION (provided by applicant): While studying the mucosal adjuvant, cholera toxin, we recently identified It Induces Th17 cell differentiation via cAMP signaling. Canonical (I.e., induced by IL-6/TGF¿) and non-canonical (i.e., induced by cAMP) Th17 subsets display different cytokine homing receptors and are regulated by different combinations of transcription factors. We hypothesize that these two Th17 subsets perform different physiological tasks especially at mucosal sites. To characterize the immunoprotective vs. immunopathogenic profiles of these Th17 subsets in the G-l mucosa, we proposed 4 specific aims (SA). In SA-1 we will characterize and compare the phenotype of the in vitro generated Th17 subsets after their adoptive transfer to recipient mice. Similarly, we will assess the inflammatory vs. regulatory function of each Th17 subset in a model of colitis. To explore the physiological role of cAMP signaling in Th17 differentiation in vivo, we generated ko mice that carry a specific deletion of the stimulatory Ga protein (Gsa) in CD4 T cells (GsaCD4 ko mice). Thus, in SA-2 we will evaluate the cytokine profile of GsaCD4 ko CD4 T cells, their homing properties to lymphoid organs and G-l mucosa, and their colitogenic profile in models of intestinal inflammation. In SA-3 we will evaluate whether GsaCD4 ko CD4 T cells mediate host protection against microbial pathogens, i.e., C. rodentium and H. pylori. We will examine the function of non-canonical Th17 cells in host defense, mucosal protection and mucosal inflammation. An important translational application of these studies is the design of cAMP-based pharmacological interventions that target the regulation of CD4 T cell functions in mucosal sites. Thus, in SA- 4 we will determine whether the administration of cAMP-elevating drugs regulate mucosal defense in the animal models described above. The results from our proposed research can facilitate the future design and development of vaccines and immunotherapies aimed at the protection of different mucosal surfaces from infections and immune-mediated pathology, which are the ultimate objectives of this RFA.
PUBLIC HEALTH RELEVANCE: In this application we will investigate two subsets of lymphocytes in models of intestinal inflammation and infection. Using appropriate mice that we generated, we will determine which of this subset is protective and which is inflammatory in the gut. Using appropriate drugs, we will attempt to modulate the inflammatory cell to function in a protective mode.
描述:研究粘膜佐剂,霍乱托米因营地信号传导(即由IL-6/TGF诱导)和非官方(即由CAMP诱导)TH17喷雾不同的细胞因子归宿Theset的转录因子在G-L粘膜中的TH17子集的粘膜位点上进行了不同的生理学转移到接受者小鼠。 CD4 T细胞中的蛋白质(GSA)(GSACD4 KO小鼠)。 T细胞介导宿主保护,即鼠尾草和幽门螺杆菌。 CD4的基于营地的药物介入目标targe的目标是cAMP的造型。表面感染和免疫介导的病理学,这是该RFA的最终目标。
公共卫生相关性:在本应用程序中,我们将在我们产生的炎症和感染模型中调查两个淋巴细胞的子集。在保护模式下发挥作用的炎症细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eyal Raz其他文献
Eyal Raz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eyal Raz', 18)}}的其他基金
A novel pathway of Th17/Th2 induction: The role of cAMP signaling in DC
Th17/Th2 诱导的新途径:cAMP 信号在 DC 中的作用
- 批准号:
10331024 - 财政年份:2019
- 资助金额:
$ 32.83万 - 项目类别:
Control of mucosal immunity by Gas- vs Gai-linked GPCR signaling in dendritic cells
树突状细胞中 Gas 与 Gai 连接的 GPCR 信号传导控制粘膜免疫
- 批准号:
9288124 - 财政年份:2016
- 资助金额:
$ 32.83万 - 项目类别:
Control of mucosal immunity by Gas- vs Gai-linked GPCR signaling in dendritic cells
树突状细胞中 Gas 与 Gai 连接的 GPCR 信号传导控制粘膜免疫
- 批准号:
9169832 - 财政年份:2016
- 资助金额:
$ 32.83万 - 项目类别:
Th17 subsets: Differential roles in immune defense mechanisms at the G-I mucosa
Th17 亚群:G-I 粘膜免疫防御机制中的不同作用
- 批准号:
8871561 - 财政年份:2011
- 资助金额:
$ 32.83万 - 项目类别:
Th17 subsets: Differential roles in immune defense mechanisms at the G-I mucosa
Th17 亚群:G-I 粘膜免疫防御机制中的不同作用
- 批准号:
8287520 - 财政年份:2011
- 资助金额:
$ 32.83万 - 项目类别:
Th17 subsets: Differential roles in immune defense mechanisms at the G-I mucosa
Th17 亚群:G-I 粘膜免疫防御机制中的不同作用
- 批准号:
8487200 - 财政年份:2011
- 资助金额:
$ 32.83万 - 项目类别:
Th17 subsets: Differential roles in immune defense mechanisms at the G-I mucosa
Th17 亚群:G-I 粘膜免疫防御机制中的不同作用
- 批准号:
8711238 - 财政年份:2011
- 资助金额:
$ 32.83万 - 项目类别:
Regulation of Mucosal Inflammation by Th17 Subsets
Th17 亚群对粘膜炎症的调节
- 批准号:
7757163 - 财政年份:2009
- 资助金额:
$ 32.83万 - 项目类别:
相似国自然基金
肿瘤微环境多层次调控的功能化纳米佐剂用于增强膀胱癌放疗疗效的机制研究
- 批准号:82303571
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向FPPS的双磷酸疫苗佐剂的开发
- 批准号:82341040
- 批准年份:2023
- 资助金额:100 万元
- 项目类别:专项基金项目
双重生物响应性自佐剂聚多肽载体构建高效mRNA癌症疫苗
- 批准号:52373299
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
新型免疫调节复合佐剂的机制研究及在疫苗开发中的应用
- 批准号:82341039
- 批准年份:2023
- 资助金额:95 万元
- 项目类别:专项基金项目
皮内接种抗原佐剂复合疫苗跨器官诱导呼吸道黏膜免疫反应
- 批准号:82341042
- 批准年份:2023
- 资助金额:100 万元
- 项目类别:专项基金项目
相似海外基金
Intra-Articular Drug Delivery Modulating Immune Cells in Inflammatory Joint Disease
关节内药物递送调节炎症性关节疾病中的免疫细胞
- 批准号:
10856753 - 财政年份:2023
- 资助金额:
$ 32.83万 - 项目类别:
Unmasking the Immunomodulatory Roles of CD7 Signaling
揭示 CD7 信号传导的免疫调节作用
- 批准号:
10637876 - 财政年份:2023
- 资助金额:
$ 32.83万 - 项目类别:
Investigating the tissue location and protective function of oral vaccine-specific tissue resident memory CD4 T cells
研究口服疫苗特异性组织驻留记忆 CD4 T 细胞的组织定位和保护功能
- 批准号:
10646930 - 财政年份:2023
- 资助金额:
$ 32.83万 - 项目类别:
Immunotherapy for Synucleinopathies: Can Gut Microbiota Affect Efficacy?
突触核蛋白病的免疫疗法:肠道微生物群会影响疗效吗?
- 批准号:
10666872 - 财政年份:2023
- 资助金额:
$ 32.83万 - 项目类别: